I don’t love it, or like it. I know it’s mostly useless, but our researchers keep mentioning it’s synergistic effects with Brilacidin, and I’m looking for things in this trial that could’ve led to bad TLD. Most patients were set up for failure IMO

I would sure hope they increase the dose of B if another trial is run, and if they cut out R all together they may be able to increase Brilacidin dose even higher without side effects